VRTHF - Veritas Pharma Inc.
| Previous Close | 0.349900 |
| Open | 0.000000 |
| Bid | 0.000000 x 0 |
| Ask | 0.000000 x 0 |
| Day's Range | 0.000000 - 0.000000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 71,430 |
| Market Cap | 21.275M |
| Beta | -1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.095000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•5 days ago
Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board
VANCOUVER, British Columbia, April 18, 2018-- Veritas Pharma Inc., is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, DSP, a consultant in safety pharmacology, has joined its advisory board. ...
- GlobeNewswire•7 days ago
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018-- Veritas Pharma Inc. is pleased ...
- GlobeNewswire•25 days ago
Veritas Pharma Closes Private Placement
VANCOUVER, British Columbia, March 29, 2018-- Veritas Pharma Inc. is pleased to announces the closing of a private placement of units. Under the terms of the Private Placement Offering, the Company will ...
- GlobeNewswire•last month
Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics
VANCOUVER, British Columbia, March 21, 2018-- Veritas Pharma Inc. is pleased to announce the Company has completed the 100% takeover of its research arm, Cannevert Therapeutics Ltd... As previously announced ...
- GlobeNewswire•last month
Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel
VANCOUVER, British Columbia, March 15, 2018-- Veritas Pharma Inc. is pleased to announce that Justin Kausel has joined the Company as Director of Business Development. Justin will report to Dr. Lui Franciosi ...
- GlobeNewswire•2 months ago
BioCan Technologies Signs Memorandum of Understanding with Veritas Pharma
CALGARY, Alberta, Feb. 28, 2018-- BioCan Technologies Inc. is pleased to announce that it has entered into a Memorandum of Understanding with Veritas Pharma Inc. to collaborate with Veritas on an exclusive ...
- PR Newswire•2 months ago
BioCan Technologies Signs Memorandum of Understanding with Veritas Pharma
CALGARY, Feb. 28, 2018 /CNW/ - BioCan Technologies Inc. ("BioCan" or the "Company") is pleased to announce that it has entered into a Memorandum of Understanding ("MoU") with Veritas Pharma Inc. ("Veritas") (CSE:VRT) (VRTHF) (Frankfurt: 2VP) to collaborate with Veritas on an exclusive basis to undertake further investigations of cannabis strains being developed by the research arm of Veritas, Cannevert Therapeutics Ltd. ("CTL"). The focus will be to optimize the genetics of their cannabis plants for scientific and clinical testing over the next two years. Pursuant to the MoU, definitive agreements in respect of the transactions contemplated in the MoU are expected to be executed by the parties on or before July 31, 2018. BioCan's CEO, Trevor Peters, stated "We are pleased to be working with Veritas and their scientific teams to develop medically relevant cannabis strains and cannabinoid formulations with optimal therapeutic properties.
- CNW Group•2 months ago
BioCan Technologies Signs Memorandum of Understanding with Veritas Pharma
BioCan Technologies Signs Memorandum of Understanding with Veritas Pharma
- GlobeNewswire•2 months ago
Veritas Pharma Signs Memorandum of Understanding with BioCan Technologies
VANCOUVER, British Columbia, Feb. 28, 2018-- Veritas Pharma Inc. is pleased to announce that it has entered into a Memorandum of Understanding with BioCan Technologies Inc. of Calgary, Alberta to collaborate ...
- GlobeNewswire•2 months ago
Veritas Pharma Completes Share Purchase Agreement of Sechelt Organic Marijuana Corp.
VANCOUVER, British Columbia, Feb. 23, 2018-- Veritas Pharma Inc., is pleased to announce that it has completed the Share Purchase Agreement with 906474 ALBERTA LTD. for 100% of Sechelt Organic Marijuana ...
- GlobeNewswire•2 months ago
Veritas Pharma Provides Corporate Update on Q1 2018
VANCOUVER, British Columbia, Feb. 21, 2018-- Veritas Pharma Inc., is pleased to provide an official corporate update on its achievements, related scientific activities and growth strategies for the first ...
- GlobeNewswire•2 months ago
Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1
VANCOUVER, British Columbia, Feb. 20, 2018-- Veritas Pharma Inc., is pleased to announce the Company and its research arm, Cannevert Therapeutics Ltd., are in process of obtaining a Fairness Opinion from ...